OrganiGram Holdings Inc. (OGI)

Market Cap	212.67M
Revenue (ttm)	119.36M
Net Income (ttm)	-5.75M
Shares Out	325.67M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	28.99
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,099,496
Open	0.595
Previous Close	0.598
Day's Range	0.594 - 0.660
52-Week Range	0.594 - 1.870
Beta	1.36
Analysts	Buy
Price Target	1.50 (+128.31%)
Earnings Date	Apr 11, 2023

About OGI

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and c...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2013
• Employees: 921
• Stock Exchange: NASDAQ
• Ticker Symbol: OGI

Financial Performance

In 2022, OGI's revenue was 145.81 million, an increase of 84.19% compared to the previous year's 79.16 million. Losses were -14.28 million, -89.07% less than in 2021.

Financial numbers in CAD

Analyst Forecast

According to 15 analysts, the average rating for OGI stock is "Buy." The 12-month stock price forecast is $1.5, which is an increase of 128.31% from the latest price.

Price Target

$1.5

(128.31% upside)

Analyst Consensus: Buy